Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 945 shares at $4.60 ($5K) on 2025-05-06, disclosed to the SEC on 2025-06-06.
Scheduled purchase ($5k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.86 | 45 | $219 | 4.5% |
| 2 | $4.75 | 45 | $214 | 4.4% |
| 3 | $4.68 | 45 | $211 | 4.4% |
| 4 | $4.60 | 45 | $207 | 4.3% |
| 5 | $4.71 | 45 | $212 | 4.4% |
| 6 | $4.50 | 45 |
| $203 |
| 4.2% |
| 7 | $4.78 | 45 | $215 | 4.5% |
| 8 | $5.25 | 45 | $236 | 4.9% |
| 9 | $5.67 | 45 | $255 | 5.3% |
| 10 | $5.68 | 45 | $256 | 5.3% |
| 11 | $5.20 | 45 | $234 | 4.9% |
| 12 | $5.37 | 45 | $242 | 5.0% |
| 13 | $4.92 | 45 | $221 | 4.6% |
| 14 | $5.41 | 45 | $243 | 5.0% |
| 15 | $5.05 | 45 | $227 | 4.7% |
| 16 | $5.10 | 45 | $229 | 4.8% |
| 17 | $5.14 | 45 | $231 | 4.8% |
| 18 | $5.27 | 45 | $237 | 4.9% |
| 19 | $5.68 | 45 | $256 | 5.3% |
| 20 | $5.66 | 45 | $255 | 5.3% |
| 21 | $4.93 | 45 | $222 | 4.6% |
| Total | $5.11 avg | 945 | $5K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |
| CPIX | BUY | 2025-04-04 | $5K | — | Filing → |